Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/59682 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Aolin Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Guang'anmen Hospital, Beijing, China. Hauptthemen laut MEDLINE: Rosacea, Punctures, Acupuncture Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Erythematotelangiectatic rosacea (ETR) is the most common subtype of rosacea, characterized by persistent facial erythema and telangiectasia of varying calibers. It causes significant aesthetic impairment and is often accompanied by uncomfortable symptoms, such as burning, stinging, dryness, and itching, profoundly affecting patients’ quality of life. Intense pulsed light (IPL) therapy demonstrates notable improvement in persistent erythema and telangiectasia; however, it is associated with issues such as a prolonged treatment course and high costs. Collateral puncture therapy involves rapid puncturing of specific acupuncture points followed by gentle squeezing around the needle holes to induce minor bleeding. Previous studies have shown that collateral puncture therapy for ETR offers advantages such as rapid onset of effect, a simple procedure, and low cost. Nevertheless, more high-quality clinical research data are needed to confirm these findings.
Objective
This study aims to observe the clinical efficacy and safety of collateral puncture therapy in treating ETR.
Methods
This study enrolled 60 patients diagnosed with ETR. The patients were randomly divided into 2 groups: one group underwent 4 sessions of collateral puncture therapy with 1-week intervals between treatments, and the other group received a single session of IPL therapy. The primary efficacy end points were the clinician’s erythema assessment and the clinician’s telangiectasia assessment. The secondary efficacy end points included the investigator’s global assessment, patient’s self-assessment, Flushing Assessment Tool results, Dermatology Life Quality Index, and Rosacea-specific Quality-of-Life instrument. The evaluation points were before treatment, immediately after treatment, and during follow-up. The data were statistically analyzed using SPSS (version 25.0; IBM Corp) to compare intragroup and intergroup differences between the 2 sets of data before and after treatment, with a significance level of α=.05 for hypothesis testing.
Results
Recruitment began on June 1, 2023. All participants have been recruited. Data analysis will be complete by the end of August 2025, with study findings available by December 2025.
Conclusions
This study has the potential to verify the clinical efficacy and safety of collateral puncture therapy in the treatment of ETR, supplement rosacea treatment methods, standardize treatment protocols, and fill a current clinical gap in treating rosacea. Trial Registration Chinese Clinical Trial Registry ChiCTR2200062639; https://www.chictr.org.cn/showproj.html?proj=177100 International Registered Report Identifier (IRRID) DERR1-10.2196/59682
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Guang'anmen Hospital, Beijing, China.
- Traditional Chinese Medicine Department, Shanghai Skin Disease Hospital, Shanghai, China.
ORCID-Profile: Aolin Song, Bingnan Cui, Xuemin Wang, Jianing Bi, Xiaohong Wu, Liu Yang, Li Liu, Shengyuan Qu, Zhu Fan, Jiao Yang, Yuhe Yan
Zitieren
APA
Song, A., Cui, B., Wang, X., Bi, J., Wu, X., Yang, L., Liu, L., Qu, S., Fan, Z., Yang, J., & Yan, Y. (2025). Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/59682
Vancouver
Song A, Cui B, Wang X, Bi J, Wu X, Yang L, et al. Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/59682
BibTeX
@article{Song2025,
author = {Song, Aolin and Cui, Bingnan and Wang, Xuemin and Bi, Jianing and Wu, Xiaohong and Yang, Liu and Liu, Li and Qu, Shengyuan and Fan, Zhu and Yang, Jiao and Yan, Yuhe},
title = {Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/59682}
}
EUVIMED